Q3 2021 Investor Relations Results

Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix References Participants Vas Narasimhan Chief Executive Officer Harry Kirsch Chief Financial Officer John Tsai Head of Global Drug Development and CMO Richard Saynor CEO, Sandoz Marie-France Tschudin President, Novartis Pharmaceuticals Karen Hale Chief Legal Officer Susanne Schaffert President, Novartis Oncology Samir Shah Global Head Investor Relations 3 Investor Relations | Q3 2021 Results NOVARTIS | Reimagining Medicine

View entire presentation